Clinical studies that investigated TMB discovered that TMB was significantly associated with the wild-type epidermal growth factor receptor (EGFR) gene and a TP53 mutation-positive status in 92 patients with lung cancer who endured surgery between 2013 and 2016 (38). Here, TP53 is linked to lung carcinoma.